Skip to main content
Erschienen in: Journal of Natural Medicines 2/2013

01.04.2013 | Original Paper

A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines

verfasst von: Andrea Medeiros, Nora Berois, Marcelo Incerti, Sylvie Bay, Laura Franco Fraguas, Eduardo Osinaga

Erschienen in: Journal of Natural Medicines | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

The Tn antigen (GalNAc-O-Ser/Thr) is one of the most specific human cancer-associated structures. In the present study we characterize the biochemical and functional properties of the Myrsine coriacea lectin (McL). We show that McL is an unusual high molecular weight highly glycosylated protein, which displays a strong Tn binding activity. The lectin exhibits in vitro inhibition of proliferation in the six cancer cell lines evaluated, in a dose-dependent manner (the strongest activity being against HT-29 and HeLa cells), whereas it does not exhibit toxicity against normal lymphocytes. McL could be exploited in the design of potential new tools for the diagnosis or treatment of cancer.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Baldus SE, Engelmann K, Hanisch FG (2004) MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci 41:189–231PubMedCrossRef Baldus SE, Engelmann K, Hanisch FG (2004) MUC1 and the MUCs: a family of human mucins with impact in cancer biology. Crit Rev Clin Lab Sci 41:189–231PubMedCrossRef
2.
Zurück zum Zitat Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H (2005) Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci 102:4572–4577PubMedCrossRef Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Okada T, Kawamoto T, Morozumi K, Narimatsu H (2005) Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc Natl Acad Sci 102:4572–4577PubMedCrossRef
3.
Zurück zum Zitat Lis H, Sharon N (1998) Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem Rev 98:637–674PubMedCrossRef Lis H, Sharon N (1998) Lectins: carbohydrate-specific proteins that mediate cellular recognition. Chem Rev 98:637–674PubMedCrossRef
4.
Zurück zum Zitat Abbott KL, Pierce JM (2010) Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers. Methods Enzymol 480:461–476PubMedCrossRef Abbott KL, Pierce JM (2010) Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers. Methods Enzymol 480:461–476PubMedCrossRef
5.
Zurück zum Zitat Liu B, Bian HJ, Bao JK (2010) Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett 287:1–12PubMedCrossRef Liu B, Bian HJ, Bao JK (2010) Plant lectins: potential antineoplastic drugs from bench to clinic. Cancer Lett 287:1–12PubMedCrossRef
6.
Zurück zum Zitat Lei HY, Chang CP (2010) Lectin of concanavalin A as an anti-hepatoma therapeutic agent. J Biomed Sci 16:10CrossRef Lei HY, Chang CP (2010) Lectin of concanavalin A as an anti-hepatoma therapeutic agent. J Biomed Sci 16:10CrossRef
7.
Zurück zum Zitat Zhou XX, Ji F, Zhao JL, Cheng LF, Xu CF (2010) Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. J Gastroenterol Hepatol 25:1266–1275PubMedCrossRef Zhou XX, Ji F, Zhao JL, Cheng LF, Xu CF (2010) Anti-cancer activity of anti-p185HER-2 ricin A chain immunotoxin on gastric cancer cells. J Gastroenterol Hepatol 25:1266–1275PubMedCrossRef
8.
Zurück zum Zitat Fu LL, Zhou CC, Yao S, Yu JY, Liu B, Bao JK (2011) Plant lectins: targeting programmed cell death pathways as antitumor agents. Int J Biochem Cell Biol 43:1442–1449PubMedCrossRef Fu LL, Zhou CC, Yao S, Yu JY, Liu B, Bao JK (2011) Plant lectins: targeting programmed cell death pathways as antitumor agents. Int J Biochem Cell Biol 43:1442–1449PubMedCrossRef
9.
Zurück zum Zitat Bakowsky H, Richter T, Kneuer C, Hoekstra D, Rothe U, Bendas G, Ehrhardt C, Bakowsky U (2008) Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochim Biophys Acta 1778:242–249PubMedCrossRef Bakowsky H, Richter T, Kneuer C, Hoekstra D, Rothe U, Bendas G, Ehrhardt C, Bakowsky U (2008) Adhesion characteristics and stability assessment of lectin-modified liposomes for site-specific drug delivery. Biochim Biophys Acta 1778:242–249PubMedCrossRef
10.
Zurück zum Zitat Wang C, Ho PC, Lim LY (2010) Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm 400:201–210PubMedCrossRef Wang C, Ho PC, Lim LY (2010) Wheat germ agglutinin-conjugated PLGA nanoparticles for enhanced intracellular delivery of paclitaxel to colon cancer cells. Int J Pharm 400:201–210PubMedCrossRef
11.
Zurück zum Zitat Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4:45–60PubMedCrossRef Hollingsworth MA, Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4:45–60PubMedCrossRef
12.
Zurück zum Zitat Brockhausen I (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599–604PubMedCrossRef Brockhausen I (2006) Mucin-type O-glycans in human colon and breast cancer: glycodynamics and functions. EMBO Rep 7:599–604PubMedCrossRef
13.
14.
Zurück zum Zitat Ju T, Otto VI, Cummings RD (2011) The Tn antigen—structural simplicity and biological complexity. Angew Chem Int Ed Engl 50:1770–1791PubMedCrossRef Ju T, Otto VI, Cummings RD (2011) The Tn antigen—structural simplicity and biological complexity. Angew Chem Int Ed Engl 50:1770–1791PubMedCrossRef
15.
Zurück zum Zitat Lo-Man R, Vichier-Guerre S, Perraut R, Deriaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C (2004) A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res 64:4987–4994PubMedCrossRef Lo-Man R, Vichier-Guerre S, Perraut R, Deriaud E, Huteau V, BenMohamed L, Diop OM, Livingston PO, Bay S, Leclerc C (2004) A fully synthetic therapeutic vaccine candidate targeting carcinoma-associated Tn carbohydrate antigen induces tumor-specific antibodies in nonhuman primates. Cancer Res 64:4987–4994PubMedCrossRef
16.
Zurück zum Zitat Galonic D, Gin D (2007) Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature 446:1000–1007PubMedCrossRef Galonic D, Gin D (2007) Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines. Nature 446:1000–1007PubMedCrossRef
17.
Zurück zum Zitat Tarp MA, Clausen H (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780:546–563PubMedCrossRef Tarp MA, Clausen H (2008) Mucin-type O-glycosylation and its potential use in drug and vaccine development. Biochim Biophys Acta 1780:546–563PubMedCrossRef
18.
Zurück zum Zitat Puri KD, Gopalakrishnan B, Surolia A (1992) Carbohydrate binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds. FEBS Lett 312:208–212PubMedCrossRef Puri KD, Gopalakrishnan B, Surolia A (1992) Carbohydrate binding specificity of the Tn-antigen binding lectin from Vicia villosa seeds. FEBS Lett 312:208–212PubMedCrossRef
19.
Zurück zum Zitat Piller V, Piller F, Cartron J-P (1986) Isolation and characterization of an N-acetylgalactosamine specific lectin from Salvia sclarea seeds. J Biol Chem 261:14069–14075PubMed Piller V, Piller F, Cartron J-P (1986) Isolation and characterization of an N-acetylgalactosamine specific lectin from Salvia sclarea seeds. J Biol Chem 261:14069–14075PubMed
20.
Zurück zum Zitat Wu AM, Wu JH, Chen Y-Y, Song S-C, Kabat EA (1999) Further characterization of the combining site of Bandeiraea (Griffonia) simplicifolia lectin-1, isolectin A4 (GSI-A4). Glycobiology 9:1161–1170PubMedCrossRef Wu AM, Wu JH, Chen Y-Y, Song S-C, Kabat EA (1999) Further characterization of the combining site of Bandeiraea (Griffonia) simplicifolia lectin-1, isolectin A4 (GSI-A4). Glycobiology 9:1161–1170PubMedCrossRef
21.
Zurück zum Zitat Osinaga E, Tello D, Batthyany C, Bianchet M, Tavares G, Duran R, Cervenansky C, Camoin L, Roseto A, Alzari P (1997) Amino acid sequence and three-dimensional structure of the Tn-specific isolectin B4 from Vicia villosa. FEBS Lett 412:190–196PubMedCrossRef Osinaga E, Tello D, Batthyany C, Bianchet M, Tavares G, Duran R, Cervenansky C, Camoin L, Roseto A, Alzari P (1997) Amino acid sequence and three-dimensional structure of the Tn-specific isolectin B4 from Vicia villosa. FEBS Lett 412:190–196PubMedCrossRef
22.
Zurück zum Zitat Babino A, Tello D, Rojas A, Bay S, Osinaga E, Alzari PM (2003) The crystal structure of a plant lectin in complex with the Tn antigen. FEBS Lett 536:106–110PubMedCrossRef Babino A, Tello D, Rojas A, Bay S, Osinaga E, Alzari PM (2003) The crystal structure of a plant lectin in complex with the Tn antigen. FEBS Lett 536:106–110PubMedCrossRef
23.
Zurück zum Zitat Medeiros A, Bianchi S, Calvete JJ, Balter H, Bay S, Robles A, Cantacuzéne D, Nimtz M, Alzari PM, Osinaga E (2000) Biochemical and functional characterization of the Tn-specific lectin from Salvia sclarea. Eur J Biochem 267:1434–1440PubMedCrossRef Medeiros A, Bianchi S, Calvete JJ, Balter H, Bay S, Robles A, Cantacuzéne D, Nimtz M, Alzari PM, Osinaga E (2000) Biochemical and functional characterization of the Tn-specific lectin from Salvia sclarea. Eur J Biochem 267:1434–1440PubMedCrossRef
24.
Zurück zum Zitat Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, Cantacuzene D, Nakada H, Alzari P (2000) Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett 469:24–28PubMedCrossRef Osinaga E, Bay S, Tello D, Babino A, Pritsch O, Assemat K, Cantacuzene D, Nakada H, Alzari P (2000) Analysis of the fine specificity of Tn-binding proteins using synthetic glycopeptide epitopes and a biosensor based on surface plasmon resonance spectroscopy. FEBS Lett 469:24–28PubMedCrossRef
25.
Zurück zum Zitat Medeiros A, Plá A, Alonso E, Batista-Viera F, Osinaga E, Franco Fraguas L (2005) Identification of a high-molecular-weight glycoconjugate from a Uruguayan plant that binds to the tumor-associated Tn antigen. Pharm Biol 43:26–32CrossRef Medeiros A, Plá A, Alonso E, Batista-Viera F, Osinaga E, Franco Fraguas L (2005) Identification of a high-molecular-weight glycoconjugate from a Uruguayan plant that binds to the tumor-associated Tn antigen. Pharm Biol 43:26–32CrossRef
26.
Zurück zum Zitat Edge ASB, Faltynek CR, Hof L, Reichert LE Jr, Weber P (1981) Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal Biochem 118:131–137PubMedCrossRef Edge ASB, Faltynek CR, Hof L, Reichert LE Jr, Weber P (1981) Deglycosylation of glycoproteins by trifluoromethanesulfonic acid. Anal Biochem 118:131–137PubMedCrossRef
27.
Zurück zum Zitat Vichier-Guerre S, Lo-Man R, Bay S, Deriaud E, Nakada H, Leclerc C, Cantacuzene D (2000) Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen. J Pept Res 55:173–180PubMedCrossRef Vichier-Guerre S, Lo-Man R, Bay S, Deriaud E, Nakada H, Leclerc C, Cantacuzene D (2000) Short synthetic glycopeptides successfully induce antibody responses to carcinoma-associated Tn antigen. J Pept Res 55:173–180PubMedCrossRef
28.
Zurück zum Zitat Malmqvist M (1993) Biospecific interaction analysis using biosensor technology. Nature 361:186–187PubMedCrossRef Malmqvist M (1993) Biospecific interaction analysis using biosensor technology. Nature 361:186–187PubMedCrossRef
29.
Zurück zum Zitat Jönsson U, Fägerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundth K, Löfas S, Persson B, Ross H, Rönnberg I, Sjölander S, Stenberg E, Stahlberg R, Urbaniczky S, Östlin H, Malmqvist M (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Bio Tech 11:620–627 Jönsson U, Fägerstam L, Ivarsson B, Johnsson B, Karlsson R, Lundth K, Löfas S, Persson B, Ross H, Rönnberg I, Sjölander S, Stenberg E, Stahlberg R, Urbaniczky S, Östlin H, Malmqvist M (1991) Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology. Bio Tech 11:620–627
30.
Zurück zum Zitat Ho JCK, Sze SCW, Shen WZ, Liu WK (2004) Mitogenic activity of edible mushroom lectins. Biochim Biophys Acta 1671:9–17PubMedCrossRef Ho JCK, Sze SCW, Shen WZ, Liu WK (2004) Mitogenic activity of edible mushroom lectins. Biochim Biophys Acta 1671:9–17PubMedCrossRef
31.
Zurück zum Zitat Kellokumpu IH (1986) Differences in lectin reactivities of cellular glycoconjugates between primary human colorectal carcinomas and their metastases. Cancer Res 46:4620–4625PubMed Kellokumpu IH (1986) Differences in lectin reactivities of cellular glycoconjugates between primary human colorectal carcinomas and their metastases. Cancer Res 46:4620–4625PubMed
32.
Zurück zum Zitat Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS (1989) Gastrointestinal Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49:197–204PubMed Itzkowitz SH, Yuan M, Montgomery CK, Kjeldsen T, Takahashi HK, Bigbee WL, Kim YS (1989) Gastrointestinal Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer. Cancer Res 49:197–204PubMed
33.
Zurück zum Zitat Chen YF, Boland CR, Kraus ER, Goldstein IJ (1994) The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116. Int J Cancer 57:561–567PubMedCrossRef Chen YF, Boland CR, Kraus ER, Goldstein IJ (1994) The lectin Griffonia simplicifolia I-A4 (GS I-A4) specifically recognizes terminal alpha-linked N-acetylgalactosaminyl groups and is cytotoxic to the human colon cancer cell lines LS174t and SW1116. Int J Cancer 57:561–567PubMedCrossRef
34.
Zurück zum Zitat Nishiyama T, Matsumoto Y, Watanabe H, Fujiwara M, Sato S (1987) Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient’s clinical course. J Natl Cancer Inst 78:1113–1118PubMed Nishiyama T, Matsumoto Y, Watanabe H, Fujiwara M, Sato S (1987) Detection of Tn antigen with Vicia villosa agglutinin in urinary bladder cancer: its relevance to the patient’s clinical course. J Natl Cancer Inst 78:1113–1118PubMed
35.
Zurück zum Zitat Terasawa K, Furumoto H, Kamada M, Aono T (1996) Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer Res 56:2229–2232PubMed Terasawa K, Furumoto H, Kamada M, Aono T (1996) Expression of Tn and sialyl-Tn antigens in the neoplastic transformation of uterine cervical epithelial cells. Cancer Res 56:2229–2232PubMed
36.
Zurück zum Zitat Konno A, Hoshino Y, Terashima S, Motoki R, Kawaguchi T (2002) Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis 19:61–70PubMedCrossRef Konno A, Hoshino Y, Terashima S, Motoki R, Kawaguchi T (2002) Carbohydrate expression profile of colorectal cancer cells is relevant to metastatic pattern and prognosis. Clin Exp Metastasis 19:61–70PubMedCrossRef
37.
Zurück zum Zitat Kawaguchi T, Takazawa H, Imai S, Morimoto J, Watanabe T, Kanno M, Igarashi S (2006) Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? Breast Cancer Res Treat 98:31–43PubMedCrossRef Kawaguchi T, Takazawa H, Imai S, Morimoto J, Watanabe T, Kanno M, Igarashi S (2006) Expression of Vicia villosa agglutinin (VVA)-binding glycoprotein in primary breast cancer cells in relation to lymphatic metastasis: is atypical MUC1 bearing Tn antigen a receptor of VVA? Breast Cancer Res Treat 98:31–43PubMedCrossRef
38.
Zurück zum Zitat De Mejia EG, Prisecaru VI (2005) Lectins as bioactive plant proteins: a potential in cancer treatment. Crit Rev Food Sci Nutr 45:425–445PubMedCrossRef De Mejia EG, Prisecaru VI (2005) Lectins as bioactive plant proteins: a potential in cancer treatment. Crit Rev Food Sci Nutr 45:425–445PubMedCrossRef
39.
Zurück zum Zitat Marth C, Daxenbichler G (1988) Peanut agglutinin inhibits proliferation of cultured breast cancer cells. Oncology 45:47–50PubMedCrossRef Marth C, Daxenbichler G (1988) Peanut agglutinin inhibits proliferation of cultured breast cancer cells. Oncology 45:47–50PubMedCrossRef
40.
Zurück zum Zitat Ryder SD, Smith JA, Rhodes JM (1992) Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells. J Natl Cancer Inst 84:1410–1416PubMedCrossRef Ryder SD, Smith JA, Rhodes JM (1992) Peanut lectin: a mitogen for normal human colonic epithelium and human HT29 colorectal cancer cells. J Natl Cancer Inst 84:1410–1416PubMedCrossRef
41.
Zurück zum Zitat Li WW, Yu JY, Xu HL, Bao JK (2011) Concanavalin A: a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics. Biochem Biophys Res Commun 414:282–286PubMedCrossRef Li WW, Yu JY, Xu HL, Bao JK (2011) Concanavalin A: a potential anti-neoplastic agent targeting apoptosis, autophagy and anti-angiogenesis for cancer therapeutics. Biochem Biophys Res Commun 414:282–286PubMedCrossRef
42.
Zurück zum Zitat Remmelink M, Darro F, Decaestecker C, De Decker R, Bovin NV, Gebhart M, Kaltner H, Gabius HJ, Kiss R, Salmon I, Danguy A (1999) In vitro influence of lectins and neoglycoconjugates on the growth of three human sarcoma cell lines. J Cancer Res Clin Oncol 125:275–285PubMedCrossRef Remmelink M, Darro F, Decaestecker C, De Decker R, Bovin NV, Gebhart M, Kaltner H, Gabius HJ, Kiss R, Salmon I, Danguy A (1999) In vitro influence of lectins and neoglycoconjugates on the growth of three human sarcoma cell lines. J Cancer Res Clin Oncol 125:275–285PubMedCrossRef
43.
Zurück zum Zitat Singh T, Wu JH, Peumans WJ, Rougé P, Van Damme EJ, Alvarez RA, Blixt O, Wu AM (2006) Carbohydrate specificity of an insecticidal lectin isolated from the leaves of Glechoma hederacea (ground ivy) towards mammalian glycoconjugates. Biochem J 393:331–341PubMedCrossRef Singh T, Wu JH, Peumans WJ, Rougé P, Van Damme EJ, Alvarez RA, Blixt O, Wu AM (2006) Carbohydrate specificity of an insecticidal lectin isolated from the leaves of Glechoma hederacea (ground ivy) towards mammalian glycoconjugates. Biochem J 393:331–341PubMedCrossRef
44.
Zurück zum Zitat Wang W, Hause B, Peumans WJ, Smagghe G, Mackie A, Fraser R, Van Damme EJM (2003) The Tn antigen-specific lectin from ground ivy is an insecticidal protein with an unusual physiology. Plant Physiol 132:1322–1334PubMedCrossRef Wang W, Hause B, Peumans WJ, Smagghe G, Mackie A, Fraser R, Van Damme EJM (2003) The Tn antigen-specific lectin from ground ivy is an insecticidal protein with an unusual physiology. Plant Physiol 132:1322–1334PubMedCrossRef
45.
Zurück zum Zitat Gastman B, Wang K, Han J, Zhu ZY, Huang X, Wang GQ, Rabinowich H, Gorelik E (2004) A novel apoptotic pathway as defined by lectin cellular initiation. Biochem Biophys Res Commun 316:263–271PubMedCrossRef Gastman B, Wang K, Han J, Zhu ZY, Huang X, Wang GQ, Rabinowich H, Gorelik E (2004) A novel apoptotic pathway as defined by lectin cellular initiation. Biochem Biophys Res Commun 316:263–271PubMedCrossRef
46.
Zurück zum Zitat Hubert P, Heitzmann A, Viel S, Nicolas A, Sastre-Garau X, Oppezzo P, Pritsch O, Osinaga E, Amigorena S (2011) Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res 71:5134–5143PubMedCrossRef Hubert P, Heitzmann A, Viel S, Nicolas A, Sastre-Garau X, Oppezzo P, Pritsch O, Osinaga E, Amigorena S (2011) Antibody-dependent cell cytotoxicity synapses form in mice during tumor-specific antibody immunotherapy. Cancer Res 71:5134–5143PubMedCrossRef
47.
Zurück zum Zitat Apostolopoulos V, Yuriev E, Ramsland PA, Halton J, Osinski C, Li W, Plebanski M, Paulsen H, McKenzie IF (2003) A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc Natl Acad Sci U S A 100:15029–15034PubMedCrossRef Apostolopoulos V, Yuriev E, Ramsland PA, Halton J, Osinski C, Li W, Plebanski M, Paulsen H, McKenzie IF (2003) A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc Natl Acad Sci U S A 100:15029–15034PubMedCrossRef
48.
Zurück zum Zitat Xu Y, Gendler SJ, Franco A (2004) Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas. J Exp Med 199:707–716PubMedCrossRef Xu Y, Gendler SJ, Franco A (2004) Designer glycopeptides for cytotoxic T cell-based elimination of carcinomas. J Exp Med 199:707–716PubMedCrossRef
49.
Zurück zum Zitat Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ (2012) Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine. Proc Natl Acad Sci U S A 109:261–266PubMedCrossRef Lakshminarayanan V, Thompson P, Wolfert MA, Buskas T, Bradley JM, Pathangey LB, Madsen CS, Cohen PA, Gendler SJ, Boons GJ (2012) Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine. Proc Natl Acad Sci U S A 109:261–266PubMedCrossRef
Metadaten
Titel
A Tn antigen binding lectin from Myrsine coriacea displays toxicity in human cancer cell lines
verfasst von
Andrea Medeiros
Nora Berois
Marcelo Incerti
Sylvie Bay
Laura Franco Fraguas
Eduardo Osinaga
Publikationsdatum
01.04.2013
Verlag
Springer Japan
Erschienen in
Journal of Natural Medicines / Ausgabe 2/2013
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-012-0671-x

Weitere Artikel der Ausgabe 2/2013

Journal of Natural Medicines 2/2013 Zur Ausgabe